Regulus Therapeutics
RGLS
#9041
Rank
โ‚น8.50 B
Marketcap
โ‚น128.40
Share price
16.28%
Change (1 day)
-45.94%
Change (1 year)

Revenue for Regulus Therapeutics (RGLS)

Revenue in 2024 (TTM): N/A

In 2023 the company made a revenue of N/A a decrease over the revenue in the year 2022 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Regulus Therapeutics from 2012 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) N/A
2023 N/A
2022 N/A
2021 N/A-100%
2020 โ‚น0.73 B50.2%
2019 โ‚น0.48 B9577.32%
2018 โ‚น5.03 M9.51%
2017 โ‚น4.59 M-94.33%
2016 โ‚น81.13 M-94.12%
2015 โ‚น1.37 B183.83%
2014 โ‚น0.48 B-59.8%
2013 โ‚น1.20 B73.86%
2012 โ‚น0.69 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น3.439 TN/A๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น4.105 TN/A๐Ÿ‡ซ๐Ÿ‡ท France
โ‚น828.25 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น4.628 TN/A๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น192.44 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น4.47 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น4.134 TN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น16.50 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA